LFVN — Lifevantage Corp

—
Nasdaq · Health Care · Pharmaceuticals · CIK 849146 ·
Last close
$4.78
Market Cap
$60.62M
52W High
$11.62
52W Low
$3.81
ADV30
40,902
Next earnings
2027-02-04
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 37,117,000 27,969,000 -136,000 -196,000 59,205,000 13,726,000 25,947,000
Jun 2026 42,377,000 33,043,000 1,667,000 1,279,000 62,111,000 14,920,000 28,522,000
Mar 2026 43,716,000 34,544,000 1,678,000 1,362,000 62,127,000 12,483,000 28,788,000
Dec 2025 48,931,000 36,209,000 487,000 276,000 61,169,000 10,181,000 28,182,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$13,079,000
Investing CF
$-8,115,000
Financing CF
$-4,089,000
CapEx
$-4,372,000
Dividends Paid
$-2,401,000
Buybacks
$-1,935,000
EPS Diluted TTM
$0.21
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-104,286,000
Inventory
$14,228,000
Receivables
$2,739,000
ST Investments
—
EBIT TTM
$3,696,000
Pretax Income TTM
$3,641,000
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$172,142,000
EBITDA
$7,189,000
Free Cash Flow
$13,403,375
Enterprise Value
$58,708,640
Total Cash
$13,726,000
Total Debt
$9,404,000
Shares Out
12,682,221
Trailing EPS
$0.21
Book Value
$2.64
ROE
8.2%
ROA
4.4%
Div Yield
4.02%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 182,586,000 6,100,000 5,072,000 62,111,000 28,522,000 33,589,000 10,241,000
Jun 2025 228,530,000 12,199,000 9,805,000 71,958,000 37,317,000 34,641,000 11,878,000
Jun 2024 200,164,000 4,332,000 2,937,000 60,299,000 34,308,000 25,991,000 12,197,000
Jun 2023 213,398,000 4,259,000 2,540,000 66,123,000 31,474,000 34,649,000 6,828,000
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$182,586,000
NetIncome TTM
$5,072,000
OpCashFlow TTM
—
Assets (Latest)
$62,127,000
Forward EPS
$0.24

Max Pain — expiry 2029-01-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $4.81 · call volume: 0 · put volume: 140

Peers — same industry

TickerNameMarket CapLastDaily %
KZIA KAZIA THERAPEUTICS LTD $60.68M $5.31 —
FBIO Fortress Biotech, Inc. $60.70M $1.82 —
ACRV Acrivon Therapeutics, Inc. $61.28M $1.43 —
CRBP Corbus Pharmaceuticals Holdings, Inc. $62.03M $3.01 —
CTOR CITIUS ONCOLOGY, INC. $57.91M $0.55 —

News headlines (Yahoo Finance, 1h cache)

Lifevantage Corp (LFVN) (Q1 2027) Earnings Call Highlights: Revenue Slides 22% as Strategic ...
2026-11-10 07:09 · Yahoo
LifeVantage Corporation Q1 2027 Earnings Call Summary
2026-11-10 02:04 · Yahoo
LifeVantage (LFVN) Q1 2027 Earnings Call Transcript
2026-11-10 01:00 · Yahoo
What Lifevantage (LFVN) Said on Its Q1 Earnings Call
2026-11-09 23:14 · Yahoo
Lifevantage: Fiscal Q1 Earnings Snapshot
2026-11-09 21:53 · Yahoo
LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
2026-11-09 21:05 · Yahoo
New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*
2026-10-29 20:05 · Yahoo
LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
2026-10-26 20:05 · Yahoo
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-12 20:05 · Yahoo
LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
2026-09-24 07:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.